Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 6.08 M5.95 M6.86 M6.45 M7.21 M8.44 M 28.96 M Research & development —————— — Operating income 17.74 M13.98 M14.17 M15.95 M21.9 M25.52 M 77.55 M Non-Operating Income, Total -524 K832 K-108 K-1.41 M1.47 M1.42 M 1.38 M Interest expense, net of interest capitalized 23.11 M22.78 M23.06 M22.4 M24.55 M30.06 M 100.07 M Non-Operating Income, excl. Interest Expenses -23.63 M-21.95 M-23.17 M-23.8 M-23.07 M-28.64 M -98.69 M Unusual income/expense —————— — Pretax income 16.35 M16.32 M14.64 M17.73 M19.97 M27.13 M 79.48 M Equity in earnings —————— — Taxes 2.78 M2.41 M2.18 M3.1 M3.71 M4.1 M 13.08 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 13.58 M13.91 M12.46 M14.64 M16.26 M23.04 M 66.4 M Discontinued operations —————— — Net income 13.58 M13.91 M12.46 M14.64 M16.26 M23.04 M 66.4 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 13.58 M13.91 M12.46 M14.64 M16.26 M23.04 M 66.4 M Basic earnings per share (Basic EPS) 0.360.370.330.40.360.39 1.48 Diluted earnings per share (Diluted EPS) 0.360.370.330.390.360.39 1.47 Average basic shares outstanding 37.38 M37.44 M37.47 M37.44 M44.65 M59.01 M — Diluted shares outstanding 37.63 M37.62 M37.68 M37.63 M44.87 M59.22 M — EBITDA 17.72 M14.43 M14.92 M17.16 M23.01 M27.39 M 82.47 M EBIT 16.56 M12.77 M13.22 M15.43 M21.01 M24.7 M 74.35 M Cost of revenue -204 K3.55 M1.42 M2.31 M-1.03 M2.44 M 5.13 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.61 M1.74 M1.7 M1.73 M2 M2.69 M 8.12 M